Mode of Action

Important Product Information

DC Bead™ Indications:

  • DC Bead™ is CE marked and is indicated for the treatment of malignant hypervascular tumours and loading with doxorubicin drug
  • DC Bead™ is also indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC).  Both indications may not be available in your territory

Cautions:

  • Embolisation with DC Bead™ should only be performed by a physician with appropriate interventional occlusion training in the region intended to be embolised
  • Exceeding a loading dose of 37.5mg doxorubicin per 1ml DC Bead™ may lead to some systemic distribution of doxorubicin and related side effect

Potential Complications:

  1. Undesirable reflux or passage of DC Bead™ into normal arteries adjacent to the targeted lesion or through the lesion into other arteries or arterial beds
  2. Non-target embolization
  3. Pulmonary embolization
  4. Ischemia at an undesirable location
  5. Capillary bed saturation and tissue damage
  6. Ischemic stroke or ischemic infarction
  7. Vessel or lesion rupture and haemorrhage
  8. Neurological deficits including cranial nerve palsies
  9. Vasospasm
  10. Death
  11. Recanalisation
  12. Foreign body reactions necessitating medical intervention
  13. Infection necessitating medical intervention

DC Bead™ and/or all indications may not be available in your territory. DC Bead™ is not currently cleared by the FDA for sale or distribution in the USA.

DC Bead is a trademark of Biocompatibles UK Ltd and DC Bead is a registered trademark in China, EU, Japan, Republic of Korea and US.

DC Bead™ is an embolic Drug-Eluting Bead capable of loading and releasing in a controlled
manner chemotherapeutic agents. DC Bead™ is used in trans-arterial chemoembolisation
(TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional
radiologist.





Mode of Action
Mode of Action (English) with subtitles



General Contact Details
Biocompatibles UK Ltd
Tel: +44 (0)1252 732732
Fax: +44 (0)1252 732777
General Email: info@biocompatibles.com
BTG International Ltd
Tel: +44 (0)20 7575 0000
Fax: +44 (0)20 7575 0010
General Email: info@btgplc.com
AccessibilityContact UsGlossaryLegal NoticeMy AccountPrivacy Policy & CookiesSitemap
© BIOCOMPATIBLES UK LTD 2014

This website is owned by Biocompatibles UK Ltd ("Biocompatibles"), a BTG International group company and is operated by Biocompatibles and its selected technology partners, which have agreed to comply with the BTG privacy policy. Please be sure to read this privacy policy before using or submitting information to this website. Use of this site constitutes your consent to application of such laws and regulations and to the terms of our privacy policy. Whenever you submit information via this site, you consent to the collection, use and disclosure of that information in accordance with this privacy policy. Your use of this site is subject to our Legal Notice and Terms of Use. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd.

.